Company / Shares Outstanding
Aligos Therapeutics, Inc. Shares Outstanding History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
79.9M
FY2025
5-year range
3.0M / 79.9M
FY2021-FY2025
Trend
+2559.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding changed +2560% YoY in FY2025, a notable deviation from the 5-year average annual change of +670%.
Based on SEC 10-K filings.
79900000.00 in FY2025 with a 5-year CAGR of +82.7%.
Increased from 42922980.00 to 79900000.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +23.2%
- 5-Year CAGR
- +82.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shares outstanding increased 2559.9% year-over-year.
- Lowest shares outstanding in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 79.9M | +2559.9% |
| FY2024 | 3.0M | -93.0% |
| FY2023 | 42.9M | +0.5% |
| FY2022 | 42.7M | +12.0% |
| FY2021 | 38.1M | +870.5% |
| FY2020 | 3.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026